A UK study found that using a polygenic risk score to identify men at highest genetic risk of prostate cancer significantly ...

The main problem is the long-standing argument that PSA is an unreliable screening tool, as PSA levels rise with age ... men aged 45 are being given PSA tests and depending on their scores are ...

Study findings provide valuable clinical information for metastatic castration-sensitive prostate cancer (mCSPC) prognosis in routine clinical practice.

There have previously been claims that Trump dictated a previous glowing medical letter and reports of recent significant ...

Routine PSA testing is not currently offered on the NHS, but patients may be offered a PSA test if a GP suspects they have prostate cancer. And men over the age of 50 can ask their ... called a ...

President Donald Trump's medical assessment is due to be published today (11 April), with questions raised as to what exactly ...

One-third of patients with PSA levels below 0.2 ng/mL after radical prostatectomy have recurrent disease identifiable by PSMA PET. More than one-third of patients with PSA levels less than 0.5 ng/mL ...

Eleven men were detected with 'abnormal PSA results' following a prostate cancer screening event in Ipswich. The event, led by Cancer Support Suffolk and CHAPS Charity at Ipswich's Venue 16, tested ...

A prostate cancer screening program involving participants in the top decile of risk according to a polygenic risk score ...

Key changes in the 2025 draft guidelines which are now open for public discussion include a world-first recommendation to offer a baseline PSA test to interested men at age 40, a strong ...

The MACE risk associated with initiating ustekinumab is comparable to that of adalimumab, etanercept, and secukinumab in patients with PsO or PsA.